Please contact email@example.com for further informationRead more..
The majority of NHS Trusts in the country are ranked as poor or satisfactory, with most of the rest achieving…Read more..
Movement Disorders Group
The movement disorders group is particularly strong in both clinical research and experimental neurophysiology, but also covers pharmacology and neurogenetics.
David Burn is Director of the Clinical Ageing Research Unit at Newcastle. The main focus of his research is the investigation and treatment of Parkinson’s Disease. He and his team are engaged in several innovative programmes and collaborations, which include developing a unique community-based Parkinson’s disease study and leading a proposal to better define depression in Parkinson’s Disease and its determinants.
Patrick Chinnery is a Professor of Neurogenetics, Wellcome Senior Fellow in Clinical Science and Honorary Consultant. Ongoing research studies span several areas including movement disorders, with genetic studies in dystonia and Parkinson’s disease.
Paul Goldsmith graduated with a triple 1st from Cambridge, a Clinical Scholarship from Oxford and undertook neurology training in Cambridge, Oxford, London and Newcastle. Following on from a PhD in disease modelling in the Anatomy Department in Cambridge he founded a biotech company, DanioLabs, establishing a number of drug discovery programmes and taking two projects into the clinic, before the Company’s acquisition. He then returned to his native North East to take up post as Consultant Neurologist at the RVI, Newcastle-upon-Tyne and is now also involved in setting up new translational research projects.
Claire Nicholson trained in functional neurosurgery in Montpellier and leads the movement disorders neurosurgery clinics. There are close links with the movement lab neurophysiology team.
Lynn Rochester Professor Rochester is Professor of Human Movement Science.